Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 3 |
2024 | 2 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
SP1-activated USP27X-AS1 promotes hepatocellular carcinoma progression via USP7-mediated AKT stabilisation.
Clin Transl Med. 2024 Jan;14(1):e1563. doi: 10.1002/ctm2.1563.
Clin Transl Med. 2024.
PMID: 38279869
Free PMC article.
Integrinβ-1 in disorders and cancers: molecular mechanisms and therapeutic targets.
Su C, Mo J, Dong S, Liao Z, Zhang B, Zhu P.
Su C, et al.
Cell Commun Signal. 2024 Jan 26;22(1):71. doi: 10.1186/s12964-023-01338-3.
Cell Commun Signal. 2024.
PMID: 38279122
Free PMC article.
Review.
Item in Clipboard
MYC in liver cancer: mechanisms and targeted therapy opportunities.
Liu F, Liao Z, Zhang Z.
Liu F, et al.
Oncogene. 2023 Nov;42(45):3303-3318. doi: 10.1038/s41388-023-02861-w. Epub 2023 Oct 13.
Oncogene. 2023.
PMID: 37833558
Review.
Item in Clipboard
ALKBH5 prevents hepatocellular carcinoma progression by post-transcriptional inhibition of PAQR4 in an m6A dependent manner.
Wang W, Huang Q, Liao Z, Zhang H, Liu Y, Liu F, Chen X, Zhang B, Chen Y, Zhu P.
Wang W, et al.
Exp Hematol Oncol. 2023 Jan 6;12(1):1. doi: 10.1186/s40164-022-00370-2.
Exp Hematol Oncol. 2023.
PMID: 36609413
Free PMC article.
Item in Clipboard
LINC01608 activated by YY1 facilitate hepatocellular carcinoma progression by modulating the EGFR/ERK axis.
Han M, Liu F, Li X, Zhang H, Pan Y, Liu Y, Zhu H, Liang H, Chen X, Liao Z, Zhang Z, Zhang B.
Han M, et al.
Liver Int. 2023 Feb;43(2):471-489. doi: 10.1111/liv.15479. Epub 2022 Nov 25.
Liver Int. 2023.
PMID: 36385489
Item in Clipboard
EIF4A3-induced circTOLLIP promotes the progression of hepatocellular carcinoma via the miR-516a-5p/PBX3/EMT pathway.
Liu Y, Song J, Zhang H, Liao Z, Liu F, Su C, Wang W, Han M, Zhang L, Zhu H, Zhang Z, Liang H, Zhang L, Zhang B, Chen X.
Liu Y, et al.
J Exp Clin Cancer Res. 2022 May 5;41(1):164. doi: 10.1186/s13046-022-02378-2.
J Exp Clin Cancer Res. 2022.
PMID: 35509064
Free PMC article.
Item in Clipboard
Cite
Cite